We are live on
!
Find out more
EEG
E.E. Geduld Portfolio holdings
AUM
$178M
1-Year Est. Return
29.34%
This Fund
S&P 500
This Quarter
Est. Return
+4.21%
1 Year Est. Return
+29.34%
3 Year Est. Return
+59.91%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$150M
AUM Growth
-$36M
(-19%)
Cap. Flow
-$46M
Cap. Flow
% of AUM
-30.71%
Top 10 Holdings %
Top 10 Hldgs %
41.15%
Holding
341
New
79
Increased
30
Reduced
42
Closed
62
Avg Time Held Equity + Options
3.4
quarters
Top 10 Avg Time Held Equity + Options
1.8
quarters
Top 20 Avg Time Held Equity + Options
2.3
quarters
Avg Time Held Equity only
3.7
quarters
Top 10 Avg Time Held Equity only
2.9
quarters
Top 20 Avg Time Held Equity only
3
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.19M |
| 2 |
LL Flooring Holdings, Inc.
LL
|
+$1.02M |
| 3 |
McDonald's
MCD
|
+$949K |
| 4 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$869K |
| 5 |
IPHI
INPHI CORPORATION
IPHI
|
+$845K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$2.08M |
| 2 |
Esperion Therapeutics
ESPR
|
+$1.61M |
| 3 |
NPSP
NPS PHARMACEUTICALS INC
NPSP
|
+$1.07M |
| 4 |
CLR
CONTINENTAL RESOURCES INC.
CLR
|
+$1.06M |
| 5 |
Loews
L
|
+$1.05M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 33.42% |
| 2 | Miscellaneous | 30.29% |
| 3 | Healthcare | 15.66% |
| 4 | Consumer Discretionary | 6.43% |
| 5 | Technology | 5.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
GCVRZ
176
DELISTED
Sanofi Contingent Value Rights
GCVRZ
| $68K | 0.05% |
100,000
| – | – |
2013 Q2
7 quarters
|
|
|
CGRN
177
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
| $65K | 0.04% |
500
| – | – |
2013 Q2
7 quarters
|
|
|
IMNP
178
DELISTED
Immune Pharmaceuticals Inc.
IMNP
| $63K | 0.04% |
1,750
| – | – |
2014 Q3
2 quarters
|
|
179
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
| $62K | 0.04% |
3,125
| – | – |
2014 Q4
1 quarter
|
|
180
Research Frontiers
REFR
$19.9M
| $61K | 0.04% |
+10,000
| New | +$52K |
2015 Q1
0 quarters
|
|
|
BXE
181
DELISTED
Bellatrix Exploration Ltd.
BXE
| $61K | 0.04% |
+5,000
| New | +$65.9K |
2015 Q1
0 quarters
|
|
|
SFXE
182
DELISTED
SFX ENTERTAINMENT, INC COM
SFXE
| $61K | 0.04% |
15,000
-35,000
| -70% | -$140K |
2014 Q4
1 quarter
|
|
183
Amarin Corp
AMRN
$244M
| $59K | 0.04% |
+1,250
| New | +$38.2K |
2015 Q1
0 quarters
|
|
|
OTE
184
DELISTED
HELLENIC TELECOMM ORG ADS(RP1/
OTE
| $55K | 0.04% |
12,500
-12,500
| -50% | -$55K |
2013 Q2
7 quarters
|
|
185
Peraso
PRSO
$5.76M
| $53K | 0.04% |
+3
| New | +$47.8K |
2015 Q1
0 quarters
|
|
|
ECTE
186
DELISTED
ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE)
ECTE
| $53K | 0.04% |
25,000
| – | – |
2013 Q2
7 quarters
|
|
|
LUB
187
CALL
DELISTED
Luby's Inc.
LUB
| $52K | 0.03% |
+10,000
| New | +$50.8K |
2015 Q1
0 quarters
|
|
188
DELISTED
Associated Banc-Corp Warrants
ASB.WS
| $52K | 0.03% |
20,480
| – | – |
2013 Q2
7 quarters
|
|
|
NBG
189
DELISTED
NATIONAL BANK OF GREECE SA ADR REPSTG 1 SHARE (NEW)
NBG
| $51K | 0.03% |
+40,000
| New | +$58.6K |
2015 Q1
0 quarters
|
|
|
PLM
190
DELISTED
PolyMet Mining Corp.
PLM
| $48K | 0.03% |
3,750
| – | – |
2013 Q2
7 quarters
|
|
191
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
| – | – |
0
| – | – |
2015 Q1
0 quarters
|
|
192
Aware
AWRE
$21.8M
| $44K | 0.03% |
10,000
| – | – |
2013 Q4
5 quarters
|
|
|
ROX
193
DELISTED
Castle Brands, Inc.
ROX
| $35K | 0.02% |
25,000
| – | – |
2013 Q2
7 quarters
|
|
|
TCF.WS
194
DELISTED
TCF Financial Corporation
TCF.WS
| $35K | 0.02% |
15,100
| – | – |
2013 Q2
7 quarters
|
|
195
DELISTED
Cel-Sci Corp Series S
CVM.WS
| $32K | 0.02% |
100,000
| – | – |
2014 Q2
3 quarters
|
|
196
Oragenics
OGEN
$2.02M
| $26K | 0.02% |
1
| – | – |
2013 Q4
5 quarters
|
|
197
DELISTED
Citigroup Inc
C.WS.A
| $18K | 0.01% |
25,000
| – | – |
2013 Q2
7 quarters
|
|
|
EMIS
198
DELISTED
EMISPHERE TECHNOLOGIES INC
EMIS
| $17K | 0.01% |
25,000
| – | – |
2013 Q2
7 quarters
|
|
|
NLST
199
DELISTED
Netlist, Inc.
NLST
| $15K | 0.01% |
+25,000
| New | +$33K |
2015 Q1
0 quarters
|
|
|
DVOX
200
DELISTED
DYNAVOX INC CL A COM STK (DE)
DVOX
| $6K | ﹤0.01% |
150,000
| – | – |
2013 Q2
7 quarters
|
|
Similar funds
BC
PFM
SRP
CF
SA
WSA
SIG
VWM
E.E. Geduld's Q1 2015 Portfolio in Review
As of Q1 2015, E.E. Geduld held 341 positions worth $150M, down 19% from $186M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
E.E. Geduld withdrew a net $46M in Q1 2015, closing 62 positions and reducing 42 holdings. Its most notable exit was Alibaba, an estimated $2.08M position sold in full.
By sector, the portfolio is most concentrated in Financials at 33% of assets, up from 31% a quarter earlier, followed by Miscellaneous and Healthcare.
Against the trend, E.E. Geduld opened a new position in Celgene Corp worth $1.15M.
- E.E. Geduld's largest Q1 2015 buy was Celgene Corp: 10,000 shares worth $1.15M.
- E.E. Geduld added most to PHARMACYCLICS INC in Q1 2015, an estimated $869K increase.
- E.E. Geduld's biggest Q1 2015 reduction was Esperion Therapeutics, cutting an estimated $1.61M.
- E.E. Geduld fully exited Alibaba in Q1 2015, selling an estimated $2.08M.
- E.E. Geduld's ten largest holdings make up 41% of its $150M portfolio in Q1 2015.
- E.E. Geduld opened 79 new positions and closed 62 in Q1 2015.
- E.E. Geduld's portfolio value fell 19% quarter-over-quarter to $150M.
Based on E.E. Geduld's 13F filing for Q1 2015, filed 1 May 2015.